Singapore Medical Device Registration Timeline: The Four-Stage Scheduling Model

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

The actual duration of a Singapore device registration equals the front-end preparation period plus the official evaluation clock plus the stop-clock period for query responses. The official evaluation clock is: Class B Full 160 working days, Abridged 100 working days, Immediate immediate upon submission; Class C Full 220, Expedited 120, Abridged 160 working days; Class D Full 310, Expedited 180, Abridged 220 working days. The front-end preparation and the query responses are not counted in the official clock, yet they are the decisive variables for the actual time to market.

  • Treating the official evaluation period as the total time is the most common scheduling error in Singapore projects, because it silently sets the S0 and S3 stages to zero.
  • The S0 entity-and-access stage can run fully in parallel with dossier preparation, including the dealer licence whose official evaluation takes 10 working days.
  • The S3 stop-clock period is the only variable the applicant controls, through dossier quality and response speed.
  • The Immediate route compresses the evaluation stage to nearly zero, so for Class B the first priority is always to check Immediate eligibility.
  • Registrations are maintained by an annual retention fee, and a lapse of more than 30 days requires a written explanation while 60 days cancels the registration.

2. Legal basis

The evaluation timelines and fees are published by HSA, the dossier format follows the ASEAN CSDT structure, and submissions run through the SHARE system, which requires authorisation through CorpPass. The clock rule is explicit: the evaluation clock stops while HSA waits for the applicant to respond to queries. The table below consolidates these sources.

ItemContent
Guidance titleGN-15, Guidance on Medical Device Product Registration, R15 (October 2026)
Fees and timelinesHSA official fees and processing times page (updated to 26 March 2026)
Submission formatGN-17 R5 / GN-18 R5 (ASEAN CSDT, October 2026)
SystemSHARE (CorpPass authorisation required)
Clock ruleThe evaluation clock stops while HSA waits for the applicant’s query responses

The four-stage scheduling model below decomposes the project into segments that can be estimated separately and then summed.

StageMain workTime characteristics
S0 Entity and accessAppoint the Registrant, sign the LoA, activate CorpPass and SHARE, confirm or apply for the dealer licenceStart in parallel; allow 2 to 8 weeks (including the dealer licence 10-working-day evaluation)
S1 Dossier preparationClassification, route justification, CSDT compilation, QMS certificate, clinical evaluation, labelingDepends on product maturity and evidence readiness
S2 Official evaluationHSA evaluation (clock running)See table above, in working days
S3 Queries and responsesHSA queries, then applicant responses (clock stopped)Determined by the number of rounds and the duration of each round; schedule separately

3. Expert insights

Insight one: treating the official period as the total time is the most common scheduling error in Singapore projects.

We repeatedly encounter clients who count backwards from 160 working days, roughly eight months, to derive their launch date, and then overrun badly. The reason is that S0 and S3 were assumed to be zero. The correct approach is to estimate the four segments separately and then add them up. Only when the entity setup, the dossier workload and the expected query traffic are each given an owner and an estimate does the total become something a launch plan can be built on, and gaps surface early enough to be closed rather than discovered at the missed launch date.

Insight two: the S0 entity and access stage can run fully in parallel, so do not serialise it.

Appointing the Registrant, signing the LoA, activating CorpPass and SHARE, and applying for the dealer licence have no dependency whatsoever on S1 dossier preparation and can proceed in parallel. The official evaluation of the dealer licence takes 10 working days, and starting it only after the dossier is ready simply wastes time. Because none of these items touches the technical content of the submission, there is no argument for sequencing them after the dossier work, and any delay here lands directly on the launch date.

Insight three: the S3 stop-clock is the only variable the applicant can control.

The official clock is fixed and cannot be changed; but the number of query rounds and your response speed per round depend entirely on dossier quality and organisational efficiency. Our hard requirement for clients is a single-round response within 10 working days. Getting the technical dossier right the first time is the biggest cost-reduction point of the Full route.

Insight four: the Immediate route compresses S2 to nearly zero.

Class B Immediate (SGD 1,000, immediate upon submission) means the official evaluation segment essentially disappears, and the total duration is almost equal to S0 plus S1. This is why we always say that checking Immediate eligibility is the first priority of any Class B project.

Insight five: the annual retention fee timing also belongs in the schedule.

The registration has no fixed validity period and is maintained by the annual retention fee (see Article 35). Do not forget to write this annual action into the project calendar, because an overdue period beyond 30 days requires a written explanation, and at 60 days the registration is cancelled.

4. Practical recommendations

  • Estimate the four segments separately and sum them: do not report only the official evaluation days.
  • Start S0 and S1 in parallel: especially CorpPass and SHARE activation and the dealer licence.
  • Set a hard target for S3: a single-round response within 10 working days, agreed in the contract with the registrant.
  • Check Immediate first for Class B: it removes the entire evaluation segment.
  • Put the annual retention fee into the compliance calendar: set a reminder 60 days in advance.

5. Verification checklist

  • □ S0 entity and access items have been started in parallel with S1
  • □ The dealer licence application has been submitted (official evaluation 10 working days)
  • □ The product class and route have been confirmed and the official evaluation clock fixed
  • □ Time for query responses has been scheduled separately with a per-round limit
  • □ Immediate eligibility has been checked for Class B
  • □ The annual retention fee has been entered into the compliance calendar
  • □ The four segments have been summed into the total time to market

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Singapore. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with HSA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail